NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ICCC

Immucell Corp

Jul 03 • 01:30PM ET

6.39

Dollar change +0.01
Percentage change 0.08	%

Healthcare • Biotechnology • USA • NASD

Peers: ZTS IDXX ELAN BIO PAHC ONC QGEN OPK CTLT PGEN

| Held by: VTI VXF IWC DFAT DCOR DFSU DFAC DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.06	Insider Own	35.60%	Shs Outstand	8.98M	Perf Week	-5.82%
Market Cap	57.79M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.82M	Perf Month	-6.91%
Enterprise Value	67.85M	PEG	-	EPS next Q	-	Inst Own	13.38%	Short Float	0.12%	Perf Quarter	17.99%
Income	-0.27M	P/S	2.12	EPS this Y	-	Inst Trans	0.29%	Short Ratio	0.21	Perf Half Y	32.68%
Sales	27.30M	P/B	1.98	EPS next Y	-	ROA	-0.61%	Short Interest	0.01M	Perf YTD	24.17%
Book/sh	3.23	P/C	12.56	EPS next 5Y	-	ROE	-1.01%	52W High	7.60 -15.86%	Perf Year	43.39%
Cash/sh	0.51	P/FCF	73.15	EPS past 3/5Y	-194.88% -6.81%	ROIC	-0.65%	52W Low	3.34 91.47%	Perf 3Y	-23.96%
Dividend Est.	-	EV/EBITDA	27.25	Sales past 3/5Y	11.25% 14.06%	Gross Margin	32.96%	Volatility	7.33% 8.14%	Perf 5Y	44.03%
Dividend TTM	-	EV/Sales	2.49	EPS Y/Y TTM	87.42%	Oper. Margin	-0.81%	ATR (14)	0.53	Perf 10Y	12.59%
Dividend Ex-Date	-	Quick Ratio	2.21	Sales Y/Y TTM	28.29%	Profit Margin	-0.99%	RSI (14)	49.61	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	4.12	EPS Q/Q	385.13%	SMA20	-2.40%	Beta	0.32	Target Price	-
Payout	-	Debt/Eq	0.51	Sales Q/Q	11.16%	SMA50	6.09%	Rel Volume	0.05	Prev Close	6.39
Employees	75	LT Debt/Eq	0.44	Earnings	May 14 AMC	SMA200	30.05%	Avg Volume	34.28K	Price	6.39
IPO	May 05, 1987	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,844	Change	0.08%

Jun-25-25 08:00AM	ImmuCell Embarks on CEO Succession Planning Process (GlobeNewswire) -10.78%
Jun-05-25 06:30AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-19-25 11:36AM	ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains (Zacks)
May-16-25 05:00PM	ImmuCell Corp (ICCC) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... (GuruFocus.com)
May-14-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire) +7.94%
08:42AM	Loading…
May-12-25 08:42AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire)
Apr-17-25 04:23AM	The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell (Zacks)
Apr-16-25 05:02PM	Top Stock Reports for Netflix, SAP & Shell (Zacks)
Apr-08-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 (GlobeNewswire) -10.59%
Apr-07-25 09:00AM	ImmuCell Hires Chief Financial Officer (GlobeNewswire)
Apr-02-25 04:05PM	ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® (GlobeNewswire) +8.40%
Feb-27-25 04:00PM	ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... (GuruFocus.com)
Feb-25-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire) +7.45%
Feb-20-25 08:19AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire)
Jan-16-25 04:05PM	ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses (GlobeNewswire) +5.16%
04:05PM	Loading…
Jan-09-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 (GlobeNewswire)
Nov-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Nov-07-24 08:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Oct-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 (GlobeNewswire)
Aug-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-07-24 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Jul-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 (GlobeNewswire)
Jun-05-24 04:05PM	ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain (GlobeNewswire)
Jun-04-24 04:05PM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire) -10.89%
May-08-24 01:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire)
Apr-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 (GlobeNewswire)
Feb-29-24 08:25AM	ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
Feb-16-24 09:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
04:05PM	Loading…
Jan-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 (GlobeNewswire) +5.01%
Nov-15-23 02:04PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.28%
Nov-13-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Nov-07-23 12:15PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 (GlobeNewswire)
Aug-29-23 08:00AM	ImmuCell Announces Submission of CMC Technical Section to the FDA (GlobeNewswire)
Aug-11-23 10:16PM	Q2 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Aug-07-23 12:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Jul-11-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023 (GlobeNewswire)
Jun-28-23 04:05PM	ImmuCell Announces Change in Timing of Anticipated FDA Submission (GlobeNewswire) -10.35%
Jun-21-23 04:05PM	ImmuCell Appoints Bryan K. Gathagan to Board of Directors (GlobeNewswire)
Jun-15-23 04:05PM	ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility (GlobeNewswire) +8.53%
May-16-23 09:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-15-23 07:36AM	There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues (Simply Wall St.) +7.11%
May-12-23 09:46PM	Q1 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents) -6.46%
May-11-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
May-04-23 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
Apr-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023 (GlobeNewswire)
Feb-23-23 05:26AM	ImmuCell Full Year 2022 Earnings: US$0.32 loss per share (vs US$0.01 loss in FY 2021) (Simply Wall St.)
Feb-21-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire) -6.84%
Feb-15-23 11:55AM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Jan-09-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022 (GlobeNewswire) +8.55%
Dec-23-22 10:24PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2022 Earnings Call Transcript (Insider Monkey)
Nov-21-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire) -11.27%
Nov-10-22 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire)
Oct-24-22 06:20AM	Investors in ImmuCell (NASDAQ:ICCC) have made a decent return of 48% over the past three years (Simply Wall St.)
Oct-05-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022 (GlobeNewswire)
Sep-14-22 05:00PM	ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Aug-12-22 09:00AM	Edited Transcript of ICCC.OQ earnings conference call or presentation 12-Aug-22 1:00pm GMT (Thomson Reuters StreetEvents) -6.86%
Aug-11-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
Aug-05-22 09:24AM	Does ImmuCell (NASDAQ:ICCC) Have A Healthy Balance Sheet? (Simply Wall St.)
Aug-04-22 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
Jul-27-22 08:05PM	ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain® (GlobeNewswire)
Jul-07-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022 (GlobeNewswire)
Jun-15-22 03:10PM	Is ImmuCell Corporation's (NASDAQ:ICCC) Stock Price Struggling As A Result Of Its Mixed Financials? (Simply Wall St.)
May-19-22 08:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-16-22 02:12PM	ImmuCell's (NASDAQ:ICCC) investors will be pleased with their respectable 35% return over the last five years (Simply Wall St.)
May-12-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire)
May-10-22 10:00AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire) -8.08%
May-05-22 01:18PM	UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
11:17AM	Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
Apr-11-22 04:05PM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022 (GlobeNewswire)
Feb-26-22 07:34AM	ImmuCell (NASDAQ:ICCC) Has A Somewhat Strained Balance Sheet (Simply Wall St.)
Feb-22-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021 (GlobeNewswire)
Feb-16-22 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021 (GlobeNewswire)
Jan-05-22 06:30AM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021 (GlobeNewswire) +10.31%
Nov-15-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021 (GlobeNewswire)
Nov-09-21 04:00PM	ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021 (GlobeNewswire)
Oct-06-21 06:30AM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021 (GlobeNewswire)
Sep-14-21 06:30AM	Raffael Lichdi, DVM Joins ImmuCells Sales & Marketing Team (GlobeNewswire) +10.17%
Sep-08-21 08:55AM	Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load? (Simply Wall St.)
Sep-07-21 08:25PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (ACCESSWIRE)
Sep-02-21 06:42PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (Newsfile) +5.25%
Aug-31-21 09:31PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (GlobeNewswire) -5.57%
Aug-29-21 06:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (ACCESSWIRE)
Aug-25-21 07:18PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (Newsfile)
Aug-24-21 07:29PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (PR Newswire) -6.05%
12:17PM	Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide (Benzinga)
06:30AM	ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain® (GlobeNewswire)
Aug-12-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021 (GlobeNewswire)
Aug-05-21 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021 (GlobeNewswire)
Jul-07-21 07:00AM	ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021 (GlobeNewswire)
Jun-10-21 01:55AM	Here's Why ImmuCell Corporation's (NASDAQ:ICCC) CEO May Deserve A Raise (Simply Wall St.) +6.56%
May-19-21 12:00PM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-21 07:15AM	ImmuCell Corp. to Host Earnings Call (ACCESSWIRE)
May-13-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021 (GlobeNewswire)
May-06-21 01:41PM	ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021 (GlobeNewswire)
Apr-19-21 04:53AM	Did You Miss ImmuCell's (NASDAQ:ICCC) Impressive 117% Share Price Gain? (Simply Wall St.) -5.66%
Apr-14-21 05:15PM	ImmuCell Closes $4,250,000 Equity Financing (GlobeNewswire)

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Basse Gloria F	Director	Jun 11 '25	Option Exercise	4.81	3,530	16,979	3,530	Jun 13 01:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICCC

Immucell Corp

Upgrade your FINVIZ experience